Interaction between propofol and sulfisoxazole in mice an in vivo and in vitro study

Research Communications in Molecular Pathology and Pharmacology

Volumn 93, Issue 1, 1996, Pages 89-100

  Costela, J L ^a   Carlos, R ^a   Zamacona, M K ^b   Jimenez R ^b   Calvo, R ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL; SULFAFURAZOLE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG POTENTIATION; DRUG PROTEIN BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX;

ANIMALS; AREA UNDER CURVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MICE; MUSCULOSKELETAL EQUILIBRIUM; PROPOFOL; SULFISOXAZOLE;

EID: 0029849337     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ahmad Y.,Pleuvry B.J. (1995). Interactions between opioid drugs and propofol in laboratory models of seizures. Br. J. Anaesth. 74, 311-314.
2. Coates D.P.,Monk C.R.,Prys-Roberts C.,Turtle M. (1987). Haemodynamic effects of infusions of the emulsion formulation of propofol during nitrous oxide anaesthesia in humans. Anesth. Analg. 66, 64-70.
3. Cockshott I.D.,Briggs L.P.,Douglas E.J.,White M. (1897). Pharmacokinetics of propofol in female patients. Br. J. Anaesth. 59, 1103-1110.
4. Cockshott I.D.,Douglas E.G.,Plummer G.F.,Simons P.J. (1992). The pharmacokinetics of propofol in laboratory animals. Xenobiotica. 22, 369-375.
5. Costela J.L.,Jiménez R, Calvo R, Suárez E.,Carlos R. (1996). Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesth. Scand. 40, in press.
6. Csögor S.I.,Kereck S.F. (1970). Enhancement of thiopentone anaesthesia by sulphafurazole. Br. J. Anaesth. 42, 988-990.
7. Chan K.,So A.P.C. (1990). The measurement of propofol in human blood samples by liquid chromatography. Methods Find. Exp. Clin. Pharmacol. 12, 135-139.
8. Chaplin M.D.,Roszkowski A.P.,Richard R.K. (1973). Displacement of thiopental from plasma proteins by nonsteroidal antiinflamatory agents. Proc. Exp. Biol. Med. 143, 667-671.
9. Dixon J.,Roberts R.M.,Tackley G.T.R.,Lewis H.,Dowell C.,Prys-Roberts. (1990). Study of the possible interactions between fentanyl and propofol using a computer-controlled infusion of propofol. Br. J. Anaesth. 64, 142-147.
10. Fulton B.,Sorkin E.M. (1995). Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 50, 636-657.
11. Garrido M.J.,Jiménez R.M.,Rodríguez-Sasiaín J.M.,Aguirre C.,Aguilera L.,Calvo R.,(1994). Characterization of the binding of propofol to plasma proteins and its possible interactions. Rev. Esp. Anestesiol. Reanim. 41, 308-312. (Spanish with an English abstract).
12. Ghoneim M.M.,Pandya H.B.,Kelley S.E.,Fischer I.J.,Corry R.S. (1976). Binding of thiopental to plasma proteins: Effects on distribution in the brain and heart. Anesthesiology 45, 635-639.
13. Goodman N.W.,Black A.M.S.,Carter J.A. (1987). Some ventilatory effects of propofol ('Diprivan') as sole anaesthetic agents. Br. J. Anaesth. 59, 1497-1503.
14. Hu O.Y.P.,Chu K.M.,Liu A.H.,Chiao S.F.,Ho W.,Ho S.T. (1993). Reinduction of the hipnotic effects of thiopental with NSAIDs by decreasing thiopental plasma protein binding in humans. Acta Anaesth. Scand. 37, 258-261.
15. Irwing S. (1964). Drug screening and evaluation of new compounds in animals. In: Animal and clinical pharmacologic techniques in drug evaluation. Edited by J. Nodine and P.E. Siegler. Year book medical publishers (Chicago). pp. 36-54.
16. Le Guellec C.L.,Lacarelle B.,Villard P.H.,Point H.,Catalin J.,Durand A. (1995). Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of differen drugs. Anesth Analg. 81, 855-861
17. Litchfield J.T.,Wilcoxon F. (1949). A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96: 99-107.
18. Lowson S.,Gent J.P.,Goodchild C.S. (1990). Anticonvulsivant properties of propofol and thiopentone: comparison using two test in laboratory mice. Br. J. Anaesth. 64, 59-63.
19. Matot Y.,Neely C.F.,Katz R.Y.,Marshall B.E. (1994). Fentanyl and propofol uptake ky the lung: effect of time between injections. Acta Anaesth. Scand. 38, 711-715.
20. Park G.R.,(1993). Pharmacokinetics and pharmacodynamics in the critically ill patient. Xenobiotica 23, 1195-1230.
21. Sebel P.S.,Lowdon J.D. (1989) Propofol. A new intravenous anesthetic. Anesthesiology 71, 260-277.
22. Servin F.,Desmonts J.M.,Haberer J.P.,Cockshott I.D.,Plummer G.F.,Farinotti R. (1988). Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 69, 887-891.
23. Shyr M.H.,Tsai T.H.,Tan P.P.C.,Chen C.F. Chan S.H.H.,(1995) Concentration and regional distribution of propofol in brain and spinal cord during propofol anesthesia in the rat. Neurosci. Lett. 184, 212-215.
24. Smith Y.,White P.F.,Nathanson M.,Gouldson R. (1994). Propofol. An update on its clinical use. Anesthesiology 81, 1005-1043.
25. Teh J, Short T.G.,Wong J, Tan P. (1994). Pharmacokinetic interacions between midazolam and propofol: an infusion study. Br. J. Anaesth. 72, 62-65.
26. Thomas V.L.,Sutton D.N.,Saunders D.A. (1988). The effect of fentanyl on propofol requirements for day case anaesthesia. Anaesthesia 43 (Suppl), 73-75.
27. Vuyk J.,Lim T.,Engbers F.H.M.,Bum A.G.L.,Vletter A.A.,Bovill, J.G. (1995). The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 83, 8-22.